PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS
Yoram Bouhnik 1
Franck Carbonnel 2
Mathurin Fumery 3
Mathurin Flamant 4
Ulrich Freudensprung 5
Janet Addison 6
1 Beaujon Hospital, Clichy, France
2 AP-HP, Paris, France
3 CHU Amiens, Nantes, France
4 Clinique Jules Verne, Nantes, France
5 Biogen International GmbH, Zug, Switzerland
6 Biogen UK, Maidenhead, United Kingdom
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]